Vimarsana.com

prnewswire palatin technologies inc: Live & Latest News Updates : Vimarsana.com

Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Jordan
United-states
American
Carl-spana
Bremelanotide-co
Exchange-commission
Prnewswire-palatin-technologies-inc
Cosette-pharmaceuticals
Sexual-dysfunction-program
Palatin-technologies-inc
Symptom-endpoints-including-the-co
Metabolic-program-obesity

Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024

Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Prnewswire-palatin-technologies-inc
Schedule-for-the-operating-results-press
International-dial
Operating-results-press-release
Conference-call
Free-dial-in-number
Dial-in-number
Access-code

Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024

/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...

United-states
Kansas
Kansas-city
American
Jesse-richards
Prnewswire-palatin-technologies-inc
Palatin-technologies-inc
University-of-oklahoma
Exchange-commission
Securities-exchange
University-kansas-school-of-medicine
Oklahoma-state-university-college

Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024

Palatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease (DED) Clinical Data Results Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Boston
American
Eric-donnenfeld
Carl-spana
Michael-raizman
Securities-exchange
Prnewswire-palatin-technologies-inc
American-society-of-cataract
Symptom-endpoints-including-the-co
Palatin-technologies-inc

Palatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3 Clinical Trial in Patients with Dry Eye Disease (DED)

On an Intent-to-Treat Analysis, Co-Primary Symptom Endpoint Met, Statistical Significance (P<0.025) Multiple Secondary Symptom Endpoints Met, Statistical...

United-states
American
Securities-exchange
Company-to-host-conference-call
Palatin-technologies-inc
Prnewswire-palatin-technologies-inc
Intent-to-treat-analysis
Co-primary-symptom-endpoint-met
Statistical-significance
Secondary-symptom-endpoints-met
Co-primary-sign-endpoint

Palatin Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

Palatin's Focus is Solely on the Development of its Melanocortin Receptor (MCR) System Pipeline PL9643 MELODY-1 Pivotal Phase 3 Study in Dry Eye Disease (DED)...

United-states
American
Carl-spana
Palatin-technologies-inc
Cosette-pharmaceuticals
Prnewswire-palatin-technologies-inc
Vyleesi-to-cosette-pharmaceuticals
Metabolic-program-obesity
Asset-sale-to-cosette-pharmaceuticals
Sexual-health-program-male-dysfunction
Bremelanotide-co
Securities-exchange

Palatin to Report Second Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on February 15, 2024

/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN) will announce its second quarter fiscal year 2024 operating results on Thursday, February 15,...

United-states
American
International-dial
Schedule-for-the-operating-results-press
Prnewswire-palatin-technologies-inc
Operating-results-press-release
Conference-call
Free-dial-in-number
Dial-in-number
Access-code
Palatin-technologies

Palatin Announces Closing of $10 Million Registered Direct Offering

Palatin Announces Closing of $10 Million Registered Direct Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
American
Prnewswire-palatin-technologies-inc
Exchange-commission
Palatin-technologies-inc
Securities-exchange
Hc-wainwright-co
Securities-act
Securities-exchange-act
Private-securities-litigation-reform-act

Palatin Announces Closing of $10 Million Registered Direct Offering

Palatin Technologies, Inc. (&quot;Palatin&quot; or the &quot;Company&quot;), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced the closing of its previously...

United-states
New-york
American
Securities-exchange
Exchange-commission
Prnewswire-palatin-technologies-inc
Palatin-technologies-inc
Hc-wainwright-co
Announces-closing
Registered-direct
Securities-act

Palatin Announces $10 Million Registered Direct Offering

Palatin Announces $10 Million Registered Direct Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
American
Prnewswire-palatin-technologies-inc
Palatin-technologies-inc
Exchange-commission
Hc-wainwright-co
Securities-exchange
Securities-act
Securities-exchange-act
Private-securities-litigation-reform-act

vimarsana © 2020. All Rights Reserved.